151 related articles for article (PubMed ID: 35183674)
1. Syndecan-1 and -4 influence Wnt signaling and cell migration in human breast cancers.
Pham SH; Pratt K; Okolicsanyi RK; Oikari LE; Yu C; Peall IW; Arif KT; Chalmers TA; Gyimesi M; Griffiths LR; Haupt LM
Biochimie; 2022 Jul; 198():60-75. PubMed ID: 35183674
[TBL] [Abstract][Full Text] [Related]
2. Syndecan-4 regulates the HER2-positive breast cancer cell proliferation cells via CK19/AKT signalling.
Pham SH; Vuorinen SI; Arif KT; Griffiths LR; Okolicsanyi RK; Haupt LM
Biochimie; 2023 Apr; 207():49-61. PubMed ID: 36460206
[TBL] [Abstract][Full Text] [Related]
3. Heparan sulfate proteoglycans and human breast cancer epithelial cell tumorigenicity.
Okolicsanyi RK; van Wijnen AJ; Cool SM; Stein GS; Griffiths LR; Haupt LM
J Cell Biochem; 2014 May; 115(5):967-76. PubMed ID: 24357546
[TBL] [Abstract][Full Text] [Related]
4. Association of heparan sulfate proteoglycans SDC1 and SDC4 polymorphisms with breast cancer in an Australian Caucasian population.
Okolicsanyi RK; Buffiere A; Jacinto JM; Chacon-Cortes D; Chambers SK; Youl PH; Haupt LM; Griffiths LR
Tumour Biol; 2015 Mar; 36(3):1731-8. PubMed ID: 25361632
[TBL] [Abstract][Full Text] [Related]
5. Heparan sulfate proteoglycans as regulators of fibroblast growth factor-2 receptor binding in breast carcinomas.
Mundhenke C; Meyer K; Drew S; Friedl A
Am J Pathol; 2002 Jan; 160(1):185-94. PubMed ID: 11786412
[TBL] [Abstract][Full Text] [Related]
6. Syndecan-1 induction in lung microenvironment supports the establishment of breast tumor metastases.
Chute C; Yang X; Meyer K; Yang N; O'Neil K; Kasza I; Eliceiri K; Alexander C; Friedl A
Breast Cancer Res; 2018 Jul; 20(1):66. PubMed ID: 29976229
[TBL] [Abstract][Full Text] [Related]
7. Syndecan-1 modulates the invasive potential of endometrioma via TGF-β signalling in a subgroup of women with endometriosis.
Ponandai-Srinivasan S; Saare M; Boggavarapu NR; Frisendahl C; Ehrström S; Riethmüller C; García-Uribe PA; Rettkowski J; Iyengar A; Salumets A; Lalitkumar PGL; Götte M; Gemzell-Danielsson K
Hum Reprod; 2020 Oct; 35(10):2280-2293. PubMed ID: 32897364
[TBL] [Abstract][Full Text] [Related]
8. Differential roles for membrane-bound and soluble syndecan-1 (CD138) in breast cancer progression.
Nikolova V; Koo CY; Ibrahim SA; Wang Z; Spillmann D; Dreier R; Kelsch R; Fischgräbe J; Smollich M; Rossi LH; Sibrowski W; Wülfing P; Kiesel L; Yip GW; Götte M
Carcinogenesis; 2009 Mar; 30(3):397-407. PubMed ID: 19126645
[TBL] [Abstract][Full Text] [Related]
9. Coordination of Heparan Sulfate Proteoglycans with Wnt Signaling To Control Cellular Migrations and Positioning in
Saied-Santiago K; Townley RA; Attonito JD; da Cunha DS; Díaz-Balzac CA; Tecle E; Bülow HE
Genetics; 2017 Aug; 206(4):1951-1967. PubMed ID: 28576860
[TBL] [Abstract][Full Text] [Related]
10. Induction of syndecan-1 expression in stromal fibroblasts promotes proliferation of human breast cancer cells.
Maeda T; Alexander CM; Friedl A
Cancer Res; 2004 Jan; 64(2):612-21. PubMed ID: 14744776
[TBL] [Abstract][Full Text] [Related]
11. Syndecan-1-Induced ECM Fiber Alignment Requires Integrin αvβ3 and Syndecan-1 Ectodomain and Heparan Sulfate Chains.
Yang N; Friedl A
PLoS One; 2016; 11(2):e0150132. PubMed ID: 26909794
[TBL] [Abstract][Full Text] [Related]
12. Localisation of specific heparan sulfate proteoglycans during the proliferative phase of brain development.
Ford-Perriss M; Turner K; Guimond S; Apedaile A; Haubeck HD; Turnbull J; Murphy M
Dev Dyn; 2003 Jun; 227(2):170-84. PubMed ID: 12761845
[TBL] [Abstract][Full Text] [Related]
13. Syndecan-1 (CD138) modulates triple-negative breast cancer stem cell properties via regulation of LRP-6 and IL-6-mediated STAT3 signaling.
Ibrahim SA; Hassan H; Vilardo L; Kumar SK; Kumar AV; Kelsch R; Schneider C; Kiesel L; Eich HT; Zucchi I; Reinbold R; Greve B; Götte M
PLoS One; 2013; 8(12):e85737. PubMed ID: 24392029
[TBL] [Abstract][Full Text] [Related]
14. Heparanase Promotes Syndecan-1 Expression to Mediate Fibrillar Collagen and Mammographic Density in Human Breast Tissue Cultured
Huang X; Reye G; Momot KI; Blick T; Lloyd T; Tilley WD; Hickey TE; Snell CE; Okolicsanyi RK; Haupt LM; Ferro V; Thompson EW; Hugo HJ
Front Cell Dev Biol; 2020; 8():599. PubMed ID: 32760722
[TBL] [Abstract][Full Text] [Related]
15. Host syndecan-1 promotes listeriosis by inhibiting intravascular neutrophil extracellular traps.
Aquino RS; Hayashida A; Park PW
PLoS Pathog; 2020 May; 16(5):e1008497. PubMed ID: 32453780
[TBL] [Abstract][Full Text] [Related]
16. Syndecan-1 Promotes Streptococcus pneumoniae Corneal Infection by Facilitating the Assembly of Adhesive Fibronectin Fibrils.
Jinno A; Hayashida A; Jenkinson HF; Park PW
mBio; 2020 Dec; 11(6):. PubMed ID: 33293379
[TBL] [Abstract][Full Text] [Related]
17. Cell surface heparan sulfate proteoglycans control adhesion and invasion of breast carcinoma cells.
Lim HC; Multhaupt HA; Couchman JR
Mol Cancer; 2015 Jan; 14(1):15. PubMed ID: 25623282
[TBL] [Abstract][Full Text] [Related]
18. Cell surface heparan sulfate proteoglycans control the response of renal interstitial fibroblasts to fibroblast growth factor-2.
Clayton A; Thomas J; Thomas GJ; Davies M; Steadman R
Kidney Int; 2001 Jun; 59(6):2084-94. PubMed ID: 11380810
[TBL] [Abstract][Full Text] [Related]
19. SDC4-rs1981429 and ATM-rs228590 may provide early biomarkers of breast cancer risk.
Vuorinen SI; Okolicsanyi RK; Gyimesi M; Meyjes-Brown J; Saini D; Pham SH; Griffiths LR; Haupt LM
J Cancer Res Clin Oncol; 2023 Jul; 149(8):4563-4578. PubMed ID: 36152082
[TBL] [Abstract][Full Text] [Related]
20. Syndecan-1 expression by stromal fibroblasts promotes breast carcinoma growth in vivo and stimulates tumor angiogenesis.
Maeda T; Desouky J; Friedl A
Oncogene; 2006 Mar; 25(9):1408-12. PubMed ID: 16247452
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
